Related Experiment Video
Updated: May 19, 2026

13:10
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Attenuated protein expression vectors for use in siRNA rescue experiments
Eiji Morita1, Jun Arii, Devin Christensen
1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Biotechniques
|August 11, 2012
Summary
Transient transfection using small interfering RNA (siRNA) is key for studying protein function. This study introduces new vectors to optimize protein re-expression, improving rescue experiments for better cellular phenotype analysis.
Area of Science:
- Molecular Biology
- Cell Biology
- Virology
Background:
- Small interfering RNA (siRNA) transfections are vital for analyzing protein function.
- Rescue experiments, crucial for validating siRNA specificity, often fail due to low exogenous protein expression.
Purpose of the Study:
- To develop and validate a set of mammalian expression vectors enabling tunable protein re-expression.
- To optimize rescue experiments following siRNA-mediated knockdown.
Main Methods:
- Development of mammalian expression vectors featuring CMV promoters of varying strengths.
- Utilizing transient transfection for siRNA delivery and exogenous protein expression.
- Assessing transfection efficiency and protein expression levels.
- Employing a CHMP2A rescue system to study HIV-1 budding.
Main Results:
- The developed vectors achieve high transfection efficiencies.
- Tunable protein expression levels were successfully demonstrated.
- Optimized rescue of siRNA-induced cellular phenotypes was achieved using the new vectors.
- The system proved effective in the context of HIV-1 budding via CHMP2A rescue.
Conclusions:
- This ensemble of expression vectors provides a robust tool for optimizing siRNA rescue experiments.
- The ability to control protein expression levels enhances the reliability of phenotypic rescue and downstream analyses.
- The system offers a valuable solution for overcoming challenges in studying protein function via knockdown and re-expression.
Related Concept Videos
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

